This site is intended for healthcare professionals in the Nordic countries.
menu
close
menu
close
Our team of medical professionals is here to help! Get answers to questions about Astellas medicines:

Today’s treatment options

Nearly 50% of postmenopausal women with symptoms of menopause do not seek help.1 

Vasomotor symptoms (VMS), also known as hot flushes and night sweats, are some of the most bothersome symptoms of menopause.2,3

Research shows that women want:4

Credible treatment information icon
Credible treatment information
Facts about diagnosis icon
Facts about diagnosis
Open and honest conversations icon
Open and honest conversations

How can you discuss with your patients the impact and severity of their VMS?

Use of hormone therapy, the most common treatment for VMS, has been declining for many years:5*

A line graph shows a drop in HT days of therapy in Germany, the UK, France, Italy, and Spain.
A line graph shows a drop in HT days of therapy in Germany, the UK, France, Italy, and Spain.

HT=hormone therapy; WHI=Women's Health Initiative.

*Data Source: IQVIA Global MIDAS 2000-2021.

†The UK left the EU on January 31, 2020.

What are the current VMS treatment options?

Today, there are several types of treatment classes for VMS.

HORMONE THERAPY

Current treatment classes for hot flushes and night sweats include hormone therapy (HT), which has long been the standard of care.6

NONHORMONAL THERAPY

There are both on and off label nonhormonal options available to treat VMS.7,8                                                                  

OTHER TREATMENT STRATEGIES

Other treatment strategies include over-the-counter remedies like supplements and herbs.6                                                            

References:

  1. Constantine GD, Graham S, Clerinx C, et al. Behaviours and attitudes influencing treatment decisions for menopausal symptoms in five European countries. Post Reprod Health 2016;22(3):112-122.
  2. Ortman JM, Velkoff VA, Hogan H. An aging nation: the older population in the United States, Current Population Reports, P25-1140. US Census Bureau, Washington, DC. 2014.
  3. Thurston RC. Vasomotor symptoms. In: Crandall CJ, Bachman GA, Faubion SS, et al., eds. Menopause Practice: A Clinician’s Guide. 6th ed. Pepper Pike, OH: The North American Menopause Society, 2019:43-55.
  4. Parish SJ, Nappi RE, Kingsberg S. Perspectives on counseling patients about menopausal hormone therapy: strategies in a complex data environment. Menopause 2018;25(8):937-949. 
  5. Lobo R. Hormone-replacement therapy: current thinking. Nat Rev Endocrinol 2017;13(4):220-231. 
  6. Kaunitz AM, Manson JE. Management of menopausal symptoms. Obstet Gynecol 2015;126(4):859-876.
  7. Hickey M, A Szabo R, S Hunter M. Non-hormonal treatments for menopausal symptoms. BMJ 2017;359:j5101
  8. https://www.ema.europa.eu/en/search?search_api_fulltext=menopause, accessed 29.05.2024

Get the latest updates and events related to VMS